March 2009

New Treatments for Retinal Vein Occlusion

Robert L. Avery, MD, Allen C. Ho, MD

In Memoriam: Yasuo Tano, MD

Yasuo Tano, MD, was Professor and Chairman, Department of Ophthalmology, Graduate School of Medicine, Osaka University.

Tatsuro Ishibashi, MD, PhD, and Shinobu Takeuchi, MD

Aboard the Orbis Flying Eye Hospital

Julia A. Haller, MD, shares her experience volunteering in Laos.

Jennifer Kreatsoulas, PhD, News & Contributing Editor

MEDICAL UPDATE

A summary of general medicine news that affects your patients, your practice, and you.

David S. Boyer, MD

The Search for Factor X

How a team approach to discovery and development led to the first anti-VEGF drug in ophthalmology.

Anthony P. Adamis, MD

Learning to Peel the ILM

An inexpensive teaching model provides a simulated environment for surgeons in training.

Anthony Correnti, MD

Should Your Organization Seek AAAHC Accreditation?

Understanding the process can help you make the decision.

Barbara Ann Harmer, RN, BSN, MHA

Using Perfluorocarbon Liquids as Short-term Postoperative Intravitreal Tamponade

Lihteh Wu, MD

Pitfalls to Consider When Using Spectraldomain OCT

Srinivas R. Sadda, MD, and Pearse Keane, MD

Intravitreal Ranibizumab for Treatment of Macular Edema Secondary to Retinal Vein Occlusion

The BRAVO and CRUISE trials are designed to evaluate the efficacy of the drug in branch and central retinal vein occlusions, respectively.

Dante J. Pieramici, MD

Update on the SCORE Study

Results are anticipated in the fall of 2009.

Ingrid U. Scott, MD, MPH

Combination Therapies for the Treatment of Retinal Vein Occlusion

Randomized controlled trials are essential to prove efficacy and establish clinical guidelines.

Michael J. Byrnes, PhD; Dayse Sena, MD, PhD; and Radouil T. Tzekov, MD, PhD

Bevacizumab for the Management of Retinal Vein Occlusions

Results suggest that intravitreal bevacizumab improves patient outcomes.

Sundeep Dev, MD, and Hersch Bhatia, BS

Shunt Vessels and Outcomes in Patients With CRVO Treated With Bevacizumab

The results of a study to investigate the impact of bevacizumab on shunt vessel developement and evaluate anatomical outcomes.

Aman Shukairy, MD; Chirag Patel, MD; Christopher Singh, MD; James Puklin, MD; and Tamer H. Mahmoud, MD, PhD

Pegaptanib for the Treatment of Ischemic Retinopathy in Patients With Diabetes and Retinal Vascular Occlusive Disorders

Michael D. Bennett, MD

Radial Optic Neurotomy for CRVO

Surgical decompression of the optic nerve head resulted in improved anatomical and visual results in most patients in a series.

E. Mitchel Opremcak, MD

Practical Applications of SD OCT in the Diagnosis and Management of Retinal Disease

The Spectralis HRA+OCT combines improved imaging and eye-tracking to improve detail and accuracy of retinal imaging.

Jeffrey S. Heier, MD

Macular Hole Closure After Vitrectomy: The Inverted Flap Technique

SOCT Copernicus HR improves visualization of the retina and increases the understanding of retina pathology.

Zosia Michalewska, MD; Janusz Michalewski, MD; and Jerzy Nawrocki, MD, PhD

Applying SD OCT for Diagnosis and Management of Exudative AMD

The RTVue SD OCT system utilizes summated en-face (C-scan) subanalysis.

Nalin J. Mehta, MD

Using 3-D Technology for Diagnosis and Patient Management

The 3D OCT-1000 combines speed and resolution to offer improved imaging.

Charles W. Mango, MD

INNOVATIONS

A preview of today's new products

Mark W. Johnson, MD

Dr. Johnson is a Professor of Ophthalmology and Visual Sciences and Director of the Vitreoretinal Service at the University of Michigan Kellogg Eye Center in Ann Arbor.

Mark W. Johnson, MD